View
0
Download
0
Category
Preview:
Citation preview
Journ
alof
Cell
Scie
nce
FHOD1 is a combined actin filament capping andbundling factor that selectively associates with actinarcs and stress fibers
Andre Schonichen1,*,`, Hans Georg Mannherz1,2, Elmar Behrmann1,§, Antonina J. Mazur2,", Sonja Kuhn1,3,Unai Silvan4, Cora-Ann Schoenenberger4, Oliver T. Fackler5, Stefan Raunser1, Leif Dehmelt6,7 andMatthias Geyer1,3,*1Department of Physical Biochemistry, Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany2Department of Anatomy and Molecular Embryology, Ruhr University Bochum, 44801 Bochum, Germany3Research Center Caesar, Ludwig-Erhard-Allee 2, 53175 Bonn, Germany4Maurice E. Muller Institute for Structural Biology, Biozentrum, University of Basel, 4056 Basel, Switzerland5Department of Infectious Diseases, Virology, University Hospital Heidelberg, INF 324, 69120 Heidelberg, Germany6Department of Systemic Biology, Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany7Department of Chemical Biology, Faculty of Chemistry, TU Dortmund, 44227 Dortmund, Germany
*Authors for correspondence (matthias.geyer@caesar.de; andre.schoenichen@gmail.com)`Present address: University of California San Francisco, Department of Cell and Tissue Biology, San Francisco, CA 94143, USA§Present address: Institute of Medical Physics and Biophysics, Charite, Universitatsmedizin Berlin, 10117 Berlin, Germany"Present address: Department of Cell Pathology, Faculty of Biotechnology, University of Wroclaw, PL-51-148 Wroclaw, Poland
Accepted 30 January 2013Journal of Cell Science 126, 1891–1901� 2013. Published by The Company of Biologists Ltddoi: 10.1242/jcs.126706
SummaryFormins are actin polymerization factors that are known to nucleate and elongate actin filaments at the barbed end. In the present studywe show that human FHOD1 lacks actin nucleation and elongation capacity, but acts as an actin bundling factor with capping activitytoward the filament barbed end. Constitutively active FHOD1 associates with actin filaments in filopodia and lamellipodia at the leading
edge, where it moves with the actin retrograde flow. At the base of lamellipodia, FHOD1 is enriched in nascent, bundled actin arcs aswell as in more mature stress fibers. This function requires actin-binding domains located N-terminally to the canonical FH1–FH2element. The bundling phenotype is maintained in the presence of tropomyosin, confirmed by electron microscopy showing assembly of
5 to 10 actin filaments into parallel, closely spaced filament bundles. Taken together, our data suggest a model in which FHOD1stabilizes actin filaments by protecting barbed ends from depolymerization with its dimeric FH2 domain, whereas the region N-terminalto the FH1 domain mediates F-actin bundling by simultaneously binding to the sides of adjacent F-actin filaments.
Key words: FHOD1, Actin bundling, Actin arcs, Stress fibers, Retrograde flow
IntroductionCell movements and dynamic changes in cell morphology play key
roles during tissue regeneration, immune responses, embryonic
development, and wound healing in eukaryotic organisms.
Remodeling of the actin cytoskeleton regulates many of the
associated cellular functions such as protrusion, adhesion, and
retraction. Although a wide array of actin filament assemblies
exists in multicellular organisms, three main categories can be
distinguished that play fundamental roles in cell migration and
cellular morphogenesis: (1) the lamellipodium, a veil-like
membrane protrusion at the leading edge of a migrating cell
containing a branched actin meshwork, (2) filopodia and
microvilli, finger-like protrusions of the plasma membrane,
stabilized by an F-actin bundle of varying thickness, and (3)
actin stress fibers that can form at least three different assembly
categories, such as dorsal stress fibers, actin arcs and ventral stress
fibers (Hotulainen and Lappalainen, 2006; Ridley, 2011).
A rich variety of regulators assembles, maintains and destroys
actin cytoskeletal structures. Among these, formins constitute the
largest and most diverse family of actin polymerization
promoting factors (Chesarone et al., 2010). Fifteen human
formin variants are known, many of which contain additional
splicing isoforms that cluster into eight different families
(Schonichen and Geyer, 2010). The defining element to all
formins is the presence of an FH2 domain that renders the protein
dimeric. For many formins (e.g. mDia1), it has been shown that the
FH2 domain promotes barbed end elongation of straight actin
filaments, most likely supported in combination with the proline-
rich FH1 domain, which concentrates actin–profilin units at the
site of polymerization. Diaphanous related formins (DRFs) contain
an additional array of regulating domains at their N-termini that
constitute a GTPase-binding domain (GBD) for activation, a
canonical FH3 domain composed of armadillo repeats and
additional helical elements. DRFs are negatively regulated by an
intra-molecular interaction of a C-terminal Diaphanous
autoregulation domain (DAD) with the N-terminal FH3 domain
(Alberts 2001; Watanabe et al., 1999), whose release is thought to
be mediated by competition displacement with an activated Rho-
GTPase (Chesarone et al., 2010; Schonichen and Geyer, 2010). In
contrast, activation of the human FH1/FH2 domain-containing
Research Article 1891
Journ
alof
Cell
Scie
nce
protein 1 (FHOD1) was shown to require phosphorylation of serine
and threonine residues within the DAD by the Rho-associated
kinase ROCK (Takeya et al., 2008).
De novo actin filament formation requires an initial nucleation
process, i.e. the stabilization of an actin dimer or trimer that acts as
nucleating seed followed by an elongation process, during which
new actin subunits are preferentially added to the fast growing plus
or barbed ends. Actin dimer or trimer formation is kinetically
unfavorable, but strongly supported by dimeric formin FH2
domains. In addition, formins support subsequent elongation
leading to rapid polymerization of straight, unbranched actin
filaments (Chesarone et al., 2010). Based on our current
understanding, formins stay bound to the barbed end of the
growing filament as leaky cappers, where they promote filament
elongation. In cells, this behavior effectively leads to transport of the
formin through the cytoplasm or into protrusions, by transmitting
forces from actin polymerization to the plasma membrane (Romero
et al., 2004; Zigmond et al., 2003). To date, the effect of full length
formins on actin polymerization has not been analyzed in vitro,
mainly due to technical issues to purify or produce the stable,
dimeric ,125 kDa multidomain protein. Instead, only deletion
constructs containing FH1 and FH2 domains of mammalian and
ascomycota formins were investigated.
In cells, FHOD1 has been shown to induce stress fiber
formation in conjunction with either activated RhoA or Rac1
GTPases (Gasteier et al., 2003; Takeya and Sumimoto, 2003;
Westendorf, 2001). Stress fibers are contractile actomyosin
bundles, which play important roles in embryonic development,
wound healing and cell migration (Hotulainen and Lappalainen,
2006). They are composed of numerous, short actin filaments with
alternating polarity (Cramer et al., 1997). These filaments are cross-
linked by a-actinin and possibly also by other actin-bundling
proteins. a-Actinin and myosin display a periodic distribution along
stress fibers typical also for other types of contractile structures, such
as myofibrils of muscle cells. In the present study, we investigated
the function of FHOD1 by performing in vitro actin polymerization
and bundling assays and followed its distribution and movements on
actin-rich structures in living cells with high temporal and spatial
resolution. Based on the functional characterization of FHOD1
domains, a model is presented, which proposes that FHOD1
stabilizes F-actin bundles by protecting barbed ends and connecting
them to adjacent actin filaments, a function that is enforced in the
presence of tropomyosin.
ResultsFHOD1 inhibits actin polymerization in vitro
To explore FHOD1’s actin assembly properties in vitro, several
FHOD1 constructs were generated (Fig. 1A). Besides the
127 kDa full length protein (fl), we generated a truncation
mutant lacking the C-terminal DAD (DC), an N-terminal deletion
mutant composed of the canonical FH1–FH2–DAD domains
(DN), a mutant containing only the N-terminal regulation
domains (N), and the central part connecting the canonical FH3
and FH1–FH2 domains (M). The FH2 domain of mDia1 served
Fig. 1. Effect of FHOD1 activity on actin polymerization in vitro. (A) Schematic illustration of FHOD1 constructs used for in vitro and cell experiments.
(B) Coomassie-stained SDS-PAGE analysis of purified FHOD1 and mDia1 constructs. (C) Negative stains of full length FHOD1 observed in electron
micrographs. (D) Time course of actin polymerization in the presence of 300 nM FHOD1 constructs fl (red), DC (blue) and DN (dark green) as well as mDia1 FH2
(green) as a positive control. All polymerization assays contained 2 mM pyrene-labeled actin. au, arbitrary units. (E) TIRFM of polymerizing 5% Alexa488-
labeled actin (1.5 mM total) alone (top panel), and in the presence of constitutively active FHOD DC (middle panel) and FHOD1 fl (bottom panel).
Journal of Cell Science 126 (8)1892
Journ
alof
Cell
Scie
nce
as control protein in all actin assembly assays. Although the
mDia1 FH2 domain could be expressed in E. coli, expression of
all recombinant FHOD1 constructs containing the FH2 domain
required the baculovirus expression system, indicating that
FHOD1’s FH2 domain potentially contains unknown structural
elements that require eukaryotic chaperones or posttranslational
modifications for proper maturation. However, all proteins could
be purified to homogeneity (Fig. 1B). Single particle electron
micrographs confirmed the integrity of full length FHOD1 by the
characteristic torus-shaped conformation (Fig. 1C).
We examined actin filament nucleation and elongation activities
of FHOD1 proteins by fluorescence measurements of pyrenyl-actin
(Fig. 1D). At a concentration of 2 mM, actin spontaneously
polymerized at a basal level, while the FH2 domain of mDia1
effectively stimulated actin elongation, similarly as described before
(Li and Higgs, 2003; Romero et al., 2004). In contrast, addition of
0.3 mM FHOD1 either as full length protein, or DC or DN variants,
almost completely inhibited actin polymerization, suggesting
capping activity of this formin (Fig. 1D). The inhibitory effect of
FHOD1 DC and fl on actin polymerization could be confirmed by
total internal reflection fluorescence (TIRF) microscopy, where no
indication of filament formation was seen (Fig. 1E). The N-terminal
FHOD1 domains 1–573 lacking the FH2 domain instead showed no
effect on actin polymerization in the pyrene-actin assay
(supplementary material Fig. S1).
In cells, expression of FHOD1 DC leads to a robust increase in
number and thickness of actin stress fibers, which suggests an
active role of this formin in cellular actin organization (Gasteier
et al., 2003; Schonichen et al., 2006). Thus, our finding that
FHOD1 might be a negative regulator of actin polymerization
was surprising and prompted us to investigate the molecular role
of FHOD1 on actin polymerization in more detail. In time
resolved actin polymerization assays, addition of the proposed
constitutively active FHOD1 DC variant in increasing
concentrations from 1 to 100 nM led to dose-dependent
inhibition of actin polymerization (Fig. 2A). A similar effect
Fig. 2. FHOD1 inhibits F-actin nucleation and elongation activity. (A) Time course of F-actin assembly in presence of increasing concentrations of FHOD1
DC. The F-actin elongation activity of 100 nM mDia1 FH2 is shown as a positive control. Pyrene-labeled actin was used at concentrations of 2 mM.
(B) Observation of actin polymerization over time in presence of 100 nM FHOD1 fl, phosphorylated FHOD1 or FHOD1 fl together with 1 mM DAD peptide.
300 nM mDia1 FH2 was used as a positive control for actin polymerization activity. (C) Time course of the basal actin polymerization activity at 2 mM
concentration with 100 nM FHOD1 DN, 3 mM profilin, and a mixture of 100 nM FHOD1 DN and 3 mM profilin. mDia1 FH2 activity is shown for comparison.
(D) Free barbed end elongation from 0.5 mM pyrenyl-actin and actin seeds in the presence of indicated concentrations of FHOD1 DC. (E) Free barbed end
elongation from 0.5 mM pyrenyl-actin and actin seeds in presence of 3 mM profilin and indicated concentrations of FHOD1 DC. (F) Plot of relative (rel.)
elongation rates (% s21) as a function of FHOD1 DC concentration in the absence or presence of 3 mM profilin. Slopes were taken at 20–60 s of the time courses
displayed in D and E. (G) Plot of F-actin depolymerization by 10-fold dilution in the absence and presence of FHOD1 fl and DC. (H). Concentration series of
FHOD1 DC in F-actin dilution assays. (I) Plot of depolymerization rates (au s21) as a function of FHOD1 DC concentration. Slopes were taken at 30–100 s of the
time course shown in H. au, arbitrary units.
FHOD1 bundling in actin arcs 1893
Journ
alof
Cell
Scie
nce
was observed when full length FHOD1 was applied (Fig. 2B),
indicating its ability to interact with actin despite presence of itsproposed autoinhibitory regulation. Addition of the DAD at 10-fold molar excess over FHOD1 fl to release a potential
autoinhibitory state did not stimulate polymerization, but againinhibited actin polymerization. Phosphorylation of FHOD1 fl byincubation with recombinant ROCK1, which had been shown toactivate the protein in cells by phosphorylation of the DAD
(Hannemann et al., 2008; Takeya et al., 2008), did not increasepolymerization, but suggested enhanced inhibition (Fig. 2B). Inpresence of 3 mM profilin, addition of the FHOD1 FH1–FH2–
DAD domain construct (DN) led again to significantly reducedpolymerization activity (Fig. 2C).
Actin filament elongation experiments were performed atreduced concentrations of 0.5 mM G-actin, which allowed
distinguishing between actin nucleation and elongationcapabilities, as they require the presence of actin seeds for freebarbed end elongation activity (Fig. 2D,E). Increasing
concentrations of FHOD1 DC led to dose-dependent reduction ofthe elongation activity both in the absence or presence of 3 mMprofilin. The inhibitory effect of FHOD1 DC was reduced in
presence of profilin, suggesting that FHOD1 is able to elongateactin filaments by incorporation of actin–profilin complexes(Fig. 2E). This effect was quantified, indicating comparable
exponential reduction of filament elongation by increasingamounts of FHOD1 DC in the presence or absence of profilinalbeit to different base-line activities (Fig. 2F). In conclusion, wecould not detect actin nucleation activity of FHOD1, neither as full
length protein nor in the truncated form lacking the autoregulationdomain, but found weak elongation activity in presence of profilin.
As FHOD1 was found to inhibit actin polymerization and
elongation, we wondered if FHOD1 is an actin filament cappingprotein. We thus examined FHOD1 fl and DC in F-actin dilutionassays and found that both proteins inhibited F-actindepolymerization (Fig. 2G,H). FHOD1 fl showed weaker
inhibition at 300 nM concentration than FHOD1 DC suggestingthat autoinhibition regulates association with F-actin barbed ends(Fig. 2G). A continuous decrease in the F-actin depolymerization
activity was observed upon increasing concentrations of FHOD1DC (Fig. 2H) as seen as well from the quantified depolymerizationrates (Fig. 2I).
FHOD1 bundles actin filaments
Activation of FHOD1 in cells induces stress fibers (Gasteier et al.,2003; Schonichen et al., 2006; Takeya and Sumimoto, 2003).
Because stress fibers contain F-actin bundles, we tested howFHOD1 binds to F-actin and if it is sufficient to induce F-actinbundles in vitro. High speed centrifugation assays revealed thatall tested FHOD1 constructs (fl, DC, DN, N and M), as well as
mDia1 FH2 appeared in the pellet fraction, and thus bind to F-actin (Fig. 3A). These results confirmed previous studies thatsuggested F-actin binding activities of an N-terminal FHOD1
construct lacking the FH2 domain (Takeya and Sumimoto, 2003).As FHOD1 N and DN do not overlap significantly in primarysequence, this observation suggests that two independent F-actin
binding sides are present in FHOD1. Interestingly, while FHOD1fl and DC bound F-actin very efficiently, only a small fraction ofconstructs FHOD1 M, DN and N and mDia1 FH2 was present in
the pellet fractions. In case of FHOD1 DN and the control proteinmDia1, this finding can be explained by binding exclusively tobarbed ends via the FH2 domain shared in these constructs.
Fig. 3. FHOD1 binds to and bundles F-actin in vitro. (A) Coomassie-
stained SDS-PAGE of FHOD1 constructs assayed in an F-actin binding assay.
FHOD1 constructs as indicated were incubated with F-actin and co-
sedimentations at high-speed centrifugation were analyzed. The presence of
FHOD1 in pellets (P) indicates F-actin binding, while proteins remaining in
the supernatants (S) do not bind F-actin. (B) Coomassie-stained SDS-PAGE
analysis of FHOD1 constructs tested for F-actin bundling activity after
incubation of proteins with F-actin and co-sedimentation at low speed. Actin
in pellet fractions indicates F-actin bundles. mDia1 FH2 served as a negative
control. (C) TIRFM of 5% Alexa488-labeled actin filaments (1.5 mM total)
only (top panel), and upon addition of 100 nM FHOD1 DC (middle panel), or
addition of 100 nM FHOD1 fl (bottom panel); see supplementary material
Movie 1. (D) Electron micrographs of FHOD1-induced actin filament
bundling. Actin filaments were incubated overnight on ice with the indicated
additives and negatively stained for EM display. Both the constitutively active
mutant (FHOD DC)- and full length FHOD-induced bundling of actin
filaments are independent of capping through gelsolin or tropomyosin
decoration. Scale bars: 1,000 nm for images and 200 nm for insets.
Journal of Cell Science 126 (8)1894
Journ
alof
Cell
Scie
nce
Because the number of barbed ends is significantly smaller thanthe number of potential binding sites along actin filaments, the
amount of FH2 domain binding in the pellet fraction is expectedto be smaller. However, the independent F-actin binding site inthe FHOD1 N-terminus might be able to bind to the sides offilaments. Additional barbed-end binding or dimerization via the
FH2 domain could increase overall actin binding efficiency.Indeed, compared to FHOD1 N and M, significantly moreFHOD1 fl and DC was pulled down by F-actin, indicating that
two regions of FHOD1 can act synergistically to increase F-actinbinding efficiency.
The F-actin bundling activity of FHOD1 constructs was next
analyzed using low speed centrifugation. The data obtainedshowed that FHOD1 fl and particularly FHOD1 DC inducedsedimentation of F-actin (Fig. 3B). Low-speed sedimentation ofactin in the presence of constructs M and DN (at the limited
amounts available) was comparable to negative controls,suggesting that those N-terminal domains themselves are notable to bundle F-actin (Fig. 3B). These data suggest that two
independent actin-binding sites at the N- and C-terminal domainsof FHOD1 cooperate for actin filament bundling. Whereas the N-terminus is likely to have F-actin side-binding activity, barbed-
end binding and/or protein dimerization via the FH2 domain isrequired for the formation of stable higher-order structurescomposed of FHOD1 and actin bundles.
To examine the capability of FHOD1 for actin bundling we
applied TIRF microscopy using polymerizing actin filaments.Two FHOD1 proteins DC and fl were added at similarconcentrations to polymerizing actin filaments using actin alone
as control. Formation of thick F-actin bundles and a rigid F-actinnetwork was indeed observed upon FHOD1 addition as actinfilaments stopped fluctuating (Fig. 3C; supplementary material
Movie 1). This effect was much stronger for FHOD1 DCcompared to fl, indicating that release of the DAD from the N-terminal FH3 recognition domain is required for full bundling
activity.
In addition we tested F-actin bundling by FHOD1 usingelectron microscopy (EM) after negative staining. FHOD1 DCand fl were incubated with freshly polymerized F-actin at molar
ratios of 1:1, 1:10, 1:100 and 1:1,000 (FHOD1 versus actinmonomer concentration) for varying periods of time. F-actin waspolymerized in the presence of the barbed end capper gelsolin at
100:1 ratio to obtain filaments of similar lengths. The actinconcentration was set to 0.1 mg/ml. Furthermore, we employedF-actin decorated with skeletal muscle tropomyosin at a molar
ratio of 7:1 in some experiments. In presence of FHOD1 fl wedetected normal appearing actin filaments and occasionallybundles comprising 2 to 3 actin filaments and in between noisysprinkles and torus-shaped structures, most probably indicating
free FHOD1 (Fig. 3D, lower panels). Otherwise no indicationwas obtained for an alteration of the filament assembly andshape. In contrast, FHOD1 DC induced F-actin bundles
containing about 2 to 5 parallel actin filaments at ratios of 1:10and 1:100 after overnight incubation at room temperature(Fig. 3D, middle panels). Upon addition of gelsolin, the actin
filaments appeared shortened, potentially due to the increasingnumber of barbed end cappers, while the bundle thicknessremained similar. FHOD1 also bundled F-actin decorated with
tropomyosin as indicated by an increase in the length andthickness of F-actin bundles compared to the treatment withgelsolin only (Fig. 3D, right panels). This suggests that the
F-actin side-binding capacity of FHOD1 is maintained uponfilament stabilization with tropomyosin.
The N-terminus of FHOD1 is necessary for localization tostress fibers
Our in vitro data suggest that FHOD1 does not nucleate andassemble actin filaments de novo as other formins but ratherbundles and stabilizes existing actin filaments. We next sought to
investigate the biological significance of these in vitro activities.Previous studies applied speckle microscopy for detection ofindividual molecular complexes of related actin regulators, suchas mDia and the Arp2/3 complex (Higashida et al., 2004;
Miyoshi et al., 2006) as individual ‘speckles’ (Danuser andWaterman-Storer, 2006; Watanabe et al., 1999). We used thismethod to detect potential enrichment of several FHOD1
constructs in subcellular structures and to study its dynamiclocalization in living cells, and focused our analysis on the actin-rich cell cortex by using TIRF microscopy. We therefore
expressed FHOD1 constructs at low levels in two mammaliancell lines: (1) Neuro-2a neuroblastoma cells expressing dominantpositive Rac1, for robust formation of large, dynamic
lamellipodia and filopodia, along with less dynamic actin arcs,and (2) COS7 fibroblast-like kidney cells, which form smaller,dynamic lamellipodia along with less dynamic ventral stressfibers terminating in focal adhesions.
In both cell types, wild-type FHOD1 co-localized strongly
with actin structures known to form anti-parallel bundles: actinarcs and ventral stress fibers (Fig. 4A,B). This localizationpattern is even more pronounced for the dominant active DC
fragment. In contrast, FHOD1 DN, which contains the proposedbarbed-end binding FH1–FH2 domains, did not show anyparticular enrichment at the actin-rich cell cortex. The N-
terminal fragment 1–573, which lacks the actin barbed-endbinding FH1–FH2 domains, also strongly localized to actin arcsand ventral stress fibers. Taken together, our data suggested thatthe N-terminal region is sufficient to confer selective binding of
FHOD1 to actin-arcs and stress fibers.
Speckle microscopy reveals contrasting dynamics ofFHOD1 and mDia1 in living cells
Constitutively active mutants of the related formin mDia1 are
highly mobile in living cells due to their processive barbed-endcapping activity. Because FHOD1 elongates actin filaments onlypoorly in vitro, we examined the dynamic behavior of individual
FHOD1 DC speckles to test, whether this constitutively activemutant shows typical motility of a processive cap in living cells.It should be noted here that the FHOD1 DN mutant is notexpected to act as a constitutively active mutant, as it is lacking
the essential N-terminal F-actin binding site. mDia1 lacks suchN-terminal F-actin binding site, and a DN mutant is widelyaccepted to be constitutively active.
Kymograph analyses in lamellipodia showed that FHOD1 DC
speckles were distributed sparsely throughout the lamellipodium,where they were predominantly shifted laterally at the speedand in the direction of retrograde flow (Fig. 5A,B, left;
supplementary material Movies 2 and 3, upper panel),suggesting that FHOD1 DC interacts with preformed actinfilaments either by binding at the side of filaments, by capping
filament ends or both. FHOD1 DC speckles localized to actin arcsat the base of the lamellipodium, which was characterized bymuch slower retrograde movements (supplementary material Fig.
FHOD1 bundling in actin arcs 1895
Journ
alof
Cell
Scie
nce
S2; Movie 4). In all actin-rich regions, most FHOD1 DC speckles
were only transiently detected for one single 400 ms frame
(supplementary material Movie 3) suggesting that cortex-
associated FHOD1 DC exchanges rapidly with a cytosolic pool.
In contrast, the dynamic behavior of mDia1 DN speckles was
highly divergent from FHOD1 DC speckles. mDia1 DN did not
translocate with the retrograde flow towards the cell interior, but
rather in the opposite direction towards the leading edge
(anterograde) at much faster speeds (Fig. 5A,B, right;
supplementary material Movies 2 and 3, lower panel). As an
apparent consequence of actin filament elongation and its
processive capping function, mDia1 DN accumulated at the
very leading edge of the cell. This is in contrast to FHOD1 DC,
which accumulated at the base of the lamellipodium. Thus, our
observation, that FHOD1 does not preferentially bind to cellular
locations enriched in barbed ends, but rather interacts transiently
with preformed actin structures, suggested that FHOD1 does not
primarily function as a processive actin filament capper.
While we never observed directional, anterograde
translocation of FHOD1 DC speckles, a small subpopulation of
FHOD1 DC speckles accumulated transiently at the leading edge
of migrating cells. In a few cases, we even observed a strong
accumulation of FHOD1 DC speckles at this cellular region
(supplementary material Fig. S2; Movie 5). However, the
dynamics of the majority of FHOD1 DC speckles was in
agreement with a role for FHOD1 as an actin filament side-
binding and capping protein, which is particularly associated with
actin filament bundles in actin arcs and stress fibers.
DiscussionIn the present study we show that human FHOD1 does not de
novo polymerize actin filaments, but instead binds dynamically to
and bundles actin filaments throughout the cell. The canonical
FH2 domain exhibits a capping activity on the actin filament
barbed end, whereas the central helical region in between the
FH3 and FH1 domains interacts with sides of actin filaments.
Given that FHOD1 DC has the strongest effect on F-actin
bundling suggests that this activity is regulated by the interaction
of the DAD with the FH3 domain. In cells, activation of FHOD1
has been shown to require phosphorylation by ROCK1
(Hannemann et al., 2008; Takeya et al., 2008). In contrast, an
activation mechanism via binding to a lipidated Rho-GTPase, as
e.g. described for mDia1 (Watanabe et al., 1999), that would lead
to retention of the formin at the plasma membrane, is not
Fig. 4. Localization of wild-type and mutant FHOD1 at cellular actin structures. Two cell systems were used to study the subcellular localization of FHOD1.
(A) Neuro2a cells expressing constitutively active Rac1 form extensive lamellipodia, filopodia and actin arcs. (B) COS7 cells also form ventral stress fibers. If
expressed at very low levels using a truncated CMV promoter (DCMV), wild-type FHOD1 speckles localize to various actin-rich structures including filopodia
and actin arcs in Neuro2a cells and on a subset of stress fibers in COS7 cells (cyan arrows). Constitutively active FHOD1 DC is enriched on actin arcs in Neuro2a
cells and strongly localized to stress fibers in COS7 cells. The N-terminal region of FHOD1 1–573 is both necessary and sufficient for its localization to actin
stress fibers, while FHOD1 DN is largely cytosolic. Wild-type FHOD1, as well as its DC variant and the 1–573 regions are largely excluded from actin-rich focal
adhesions (cyan arrowheads). The corresponding FHOD1 image panels within each cell type were all acquired and scaled with identical settings to allow
comparison of expression level. Insets are magnified 36 from original panels and optimized individually for display purposes.
Journal of Cell Science 126 (8)1896
Journ
alof
Cell
Scie
nce
observed for FHOD1 (Schulte et al., 2008). Instead, activated
FHOD1 transiently associates with various actin structures and
ultimately accumulates in actin arcs and stress fibers, where it
could protect the filament strain from depolymerization while
simultaneously binding to neighboring actin filaments. FHOD1
thus represents a new class of actin regulators by combining
capping activity at the barbed end with F-actin side-binding
activity to effectively protect actin filaments in cytoskeletal
structures.
Formins were identified as de novo actin filament nucleators
and are often referred to as actin nucleating factors in the current
literature. However, we could not confirm a ‘formin-typical’
Fig. 5. Intracellular dynamics of FHOD1 and
mDia1 formins. (A) Kymographs (right-hand panel)
show that many speckles of the constitutively active
FHOD1 DC formin undergo short but continuous
retrograde movements at speeds similar to retrograde
actin flow within the lamellipodium (supplementary
material Movie 2, upper panel). In contrast, speckles
of constitutively active mDia1 DN either remain at
the very leading edge or appear transiently for a
single image frame within the lamellipodium
(supplementary material Movie 2, lower panel).
(B) At higher frame rates, continuous anterograde
movements of mDia1 DN toward the leading edge
can be resolved, which were similar in speed to
previous reports on single molecule dynamics of this
formin mutant (Watanabe and Mitchison, 2002). Such
fast anterograde movements are not observed for
constitutively active FHOD1 DC (supplementary
material Movie 3). (C) Model for FHOD1-mediated
actin filament bundling and stress fiber stabilization.
FHOD1 is activated at the plasma membrane through
phosphorylation of its DAD by the Rho-associated
kinase ROCK1. Activated FHOD1 associates with
both barbed ends and actin filament sides and
assembles into actin arcs and stress fibers. Other
cytoskeleton stabilizing factors, such as a-actinin,
myosin II and gelsolin, might complement the
capping and bundling activity of FHOD1.
FHOD1 bundling in actin arcs 1897
Journ
alof
Cell
Scie
nce
activity for FHOD1, but found that FHOD1 inhibits de novo actinnucleation in vitro. FHOD1 does not seem to be an outlier in this
respect as some formins inhibit rather than increase actinpolymerization in vitro, including FHOD3 (Taniguchi et al.,2009), and FMNL2 (Block et al., 2012). Hence, nucleation ofactin filaments in vitro does not appear to be a common property
of formins. In fact, it is emerging that actin nucleation activity offormins may involve additional cellular co-factors: The yeastformin Bni1 interacts via the FH2 domain with the polarity factor
Bud6 (Moseley and Goode, 2005; Tu et al., 2012), the drosophilaformin Cappuccino and Spire cooperate for actin nucleation(Quinlan et al., 2007), and mDia1 synergizes with the APC
(adenomatous polyposis coli) protein for actin nucleation(Breitsprecher et al., 2012; Okada et al., 2010). Thus, wecannot rule out that FHOD1 may associate with an additionalfactor for actin nucleation in cells. FHOD1 has been shown not
only to be activated by but also to interact with ROCK1 via theN-terminal half of its FH2 domain (Hannemann et al., 2008), andthus ROCK1 may be a candidate to potentially cooperate in actin
filament nucleation.
It has been reported that the FH2 domain of certain formins,such as mDia2, is able to bundle actin filaments in vitro (Harris
et al., 2006). Although mDia2 indeed stabilizes cortical actin andfree actin filament barbed ends in focal adhesions (Gupton et al.,2007), it remains unclear whether actin filament bundling activity
by the FH2 domain is relevant in cells. However, for the FHOD1FH2 domain we neither observe actin filament bundling activityin vitro nor does it localize to F-actin in cells. In contrast, N-terminal binding regions of FHOD1 are required for in vitro
bundling activity, which is also required for F-actin localization.Hence, our data suggest that the mechanisms for actin filamentsbundling of FHOD1 and other formins differ strongly.
Live-cell imaging using EGFP–FHOD1 and mCherry–actinrevealed that FHOD1 localized near the plasma membrane toassociate with cortical F-actin. Interestingly, for a close
homologue to FHOD, ForC from Dictyostelium discoideum, theN-terminal putative GTPase binding domain was shown tointeract with phosphoinositides in vitro and was required forForC targeting to cell–cell contacts and early phagocytic cups in
cells (Dames et al., 2011). Similarly to FHOD1, this domainexhibits the ubiquitin superfold, and its appearance in domainarchitecture and structure is reminiscent to the F0 domain in
Kindlin and Talin proteins that is known to target FERM proteinsto focal adhesions (Legate et al., 2011; Perera et al., 2011).Deletion of the N-terminal region 1–115 in FHOD1 abrogates its
capability to stabilize actin fibers (Schulte et al., 2008) indicatingthat association to the plasma membrane might be required forFHOD1 function. Of note, ForC does not contain a proline-rich
FH1 domain that could recruit profilin–actin complexes for actinpolymerization, indicating a loss of actin polymerization activityin ForC, and supporting properties of FHOD1 described in thepresent paper.
The F-actin bundling mechanism identified in the presentstudy fits well to the known biological properties of FHOD1.Similar to other diaphanous formins, activated forms of FHOD1
potently induce the formation of F-actin stress fibers inmammalian cells (Gasteier et al., 2003; Schulte et al., 2008;Westendorf, 2001). As a notable difference to other DRFs, these
stress fibers are significantly thicker and FHOD1 remainsassociated with these filament bundles to decorate the stressfibers. This phenomenon can now be attributed to FHOD1’s
unique properties such as sustained barbed end association andfilament bundling. Moreover, the mobility of filament-associated
FHOD1 away from the plasma membrane observed by live cellimaging explains why FHOD1 specifically facilitates theformation of cytoplasmic F-actin structures such as stress fibersand actin arcs. Another common feature of formins consists of
their ability to induce the nuclear transcription serum responsefactor (SRF) to modulate the expression of specific target genes(Tominaga et al., 2000). This effect mirrors formin-mediated
regulation of actin dynamics since enhanced actin polymerizationliberates myocardin-related transcription factor (MRTF)cofactors from G-actin to facilitate their import into the nucleus
and subsequent activation of transcription (Jurmeister et al.,2012; Staus et al., 2011). As activated FHOD1 acts as potentinducer of SRF-mediated transcription (Gasteier et al., 2003;Westendorf, 2001) without inducing de novo actin
polymerization, our results indicate that reducing G-actin pools,e.g. by stabilization and/or bundling of F-actin structures, cansuffice for the induction of transcriptional responses.
ROCK1 activation leads to increased actin stress fiberformation via myosin light chain phosphorylation (Wojciak-Stothard et al., 2001). However, whether FHOD1 and myosin
light chain phosphorylation act cooperatively or independently toincrease actin stress fibers and whether they regulate differentarchitectures of bundled actin filaments is unknown. FHOD1
may stabilize and bundle assembled stress fibers, while myosinmotors generate force for contraction. Alternatively, FHOD1could elongate barbed ends with its FH2 domain while the N-terminal domains stay bound to adjacent actin filaments for
anchoring the formin. As FH2 domains can generate piconewtonforces, this could be an alternative mechanism for contraction(Kovar and Pollard, 2004).
The filament stabilizing function ascribed to FHOD1 in thepresent study is in line with recent analyses of FHOD1 (Mi-Miet al., 2012) and FHOD3 (Iskratsch et al., 2010; Taniguchi et al.,
2009) on the regulation of actin assembly and sarcomereorganization in muscle cells. A specific splice variant ofFHOD3 was shown to be located mainly in the Z disc of themature heart muscle and may thus assist actin turnover or
reduced barbed end depolymerization (Iskratsch et al., 2010). Inmature myofibrils, both pointed and barbed ends of the thinfilaments are capped and stabilized by tropomodulin and CapZ,
respectively. While the mechanism of thin filament assembly andmaintenance are still under debate (Sparrow and Schock, 2009),FHOD3 as a barbed end capping protein could adopt a function
similar to CapZ in muscle cells. Notably, FHOD3 is about 250amino acids longer in size than FHOD1. Whereas the GBD–FH3and FH1–FH2 elements align overall well between both
homologues, it is particularly the connecting region identifiedin the present study as F-actin side binding element (construct M,Fig. 1A) that varies substantially between both proteins. Thissuggests that the mode of bundling to neighboring filaments by
this region in FHOD1 could adopt an alternative function in theassembly mechanism mediated by its homologue FHOD3, e.g. incardiomyocytes and striated muscle cells.
On the basis of these results we propose a model, in whichFHOD1 selectively stabilizes actin filaments by associating to thegrowing actin filament at the side of filament polymerization and
travelling with the filament into cell shape maintainingcytoskeletal substructures (Fig. 5C). FHOD1 could sustain actinarc formations at nascent focal adhesions that were recently
Journal of Cell Science 126 (8)1898
Journ
alof
Cell
Scie
nce
proposed to mediate cellular protrusions (Burnette et al., 2011),
or associate to stress fibers, which are highly decorated with
myosin II and tropomyosin (Tojkander et al., 2011). The
combination of capping activity at the filament barbed end with
F-actin side-binding activity appears complementary to other
bundling factors as a-actinin or capping factors as gelsolin,
whose expression levels are however much higher in eukaryotic
cells. These distinct cross-linkers could associate transiently to
the actin filaments to orchestrate the reorganization of stress
fibers. The diverging regulatory pathways that control these
cross-linkers are integrated into the filament reorganization
process and may allow for the cytoskeletal dynamics and
plasticity. With these features, the mammalian formin FHOD1
represents a new class of actin regulators to effectively protect
and bundle actin filaments.
Material and MethodsCloning, expression and purification of recombinant FHOD1
Detailed protocols of plasmid cloning, protein expression and purification ofrecombinant FHOD1 are provided in the supplementary material. Briefly, plasmidsencoding human FHOD1 1–573, 1–377 and 396–573 as well as mouse mDia1748–1175 were transformed into T1 phage resistant BL21(DE3) cells, expressed at20 C for 14 h and purified following standard protocols. FHOD1 constructscontaining the FH2 domain (FHOD1 fl, DC and DN) were expressed in Sf21 cellsusing a baculovirus expression system and purified as N-terminally His-taggedfusion proteins.
Plasmids encoding human FHOD1 1–573, 1–377 and 396–573 as well as mousemDia1 748–1175 were transformed into T1 phage resistant BL21(DE3) cells andexpressed at 20 C for 14 h after induction with isopropyl-b-D-1-thiogalactopyranoside. Cells were harvested by a 20 min centrifugation step at4,500 g, resuspended in buffer A (50 mM Hepes pH 7.6, 150 mM NaCl, 5 mMEDTA, 1 mM DTE, 1 mM PMSF) and lysed using a microfluidizer. The lysatewas cleared by centrifugation at 10,000 g for 45 min. GST fusion proteins werepurified using GSH Sepharose FastFlow (GE Healthcare) using Akta Prime FPLCsystems. The resin was washed with buffer A and B (50 mM NaPi pH 8, 1 MNaCl, 5 mM EDTA, 1 mM DTE, 1 mM PMSF) until A280 reached zero. GSTfusion proteins were eluted with buffer A containing 10 mM GSH. Fractionscontaining the fusion protein were pooled and treated with TEV protease (home-made) in a molar ratio of 1:200 at 4 C overnight.
FHOD1 constructs containing the FH2 domain (FHOD1 fl, DC and DN) wereexpressed in Sf21 cells (Invitrogen) using the pFastBac baculovirus expressionsystem (Invitrogen). Sf21 cells were transfected using Lipofectamine (Invitrogen)with plasmids encoding N-terminally His-tagged fusion proteins. After virusamplification, Sf21 cultures were infected with concentrated virus stock andproteins were expressed for 72 h at 27 C. Cells were harvested by centrifugation at2,500 g for 20 min at 4 C, and lysed in buffer C (50 mM Hepes pH 8, 500 mMNaCl, 20 mM imidazole, 5 mM b-mercaptoethanol, 1 mM PMSF) by sonication.The cleared lysate was applied to Ni-NTA resin (Qiagen). The resin was washedwith buffer C until the OD280 reached zero. Proteins were eluted by running agradient from 20 to 250 mM imidazole in buffer C. Peak fractions were analyzedby SDS-PAGE and fractions containing the proteins of interest were pooled,concentrated and treated with TEV protease.
After protease cleavage, the protein solution was concentrated at 3,500 g usingAmicon Ultra-15 centrifugation devices with the appropriate pore size (Millipore).2 ml protein solutions were applied to a Superdex S75 16/60 column (GEHealthcare), equilibrated in buffer D (20 mM Hepes pH 7.5, 50 KCl, 1 mMMgCl2, 1 mM EGTA, 1 mM DTT) with a GSH or Ni-NTA column attached inseries. FHOD1 proteins eluted at its expected monomer or dimer (constructsencompassing FH2 domains) weight. Homogeneity and identity of FHOD1proteins were determined by SDS-PAGE analysis and eventually electrospraymass spectrometry, respectively. Proteins containing the FH2 domain wereimmediately studied in pyrene assay measurements or stored at 4 C for less thanone week. All other proteins were stored at 280 C. Profilin was expressed as His-tagged protein, purified by standard Ni-NTA chromatography and stored at280 C. For speckle microscopy, FHOD1 constructs were subcloned into a pEGFP-based vector (Clontech), which was modified to contain a minimal CMV promoter(DCMV) (Watanabe and Mitchison, 2002).
Actin polymerization experiments
Actin nucleation and F-actin elongation assays were performed as described(Moseley et al., 2004). All proteins investigated were carefully dialyzed or gelfiltrated in buffer B to avoid artifacts due to buffer differences. Pyrene-labeledactin was purchased from Cytoskeleton Inc., and dissolved to a concentration of
20 mg/ml. 5 ml aliquots were stored at 280 C. After thawing, one aliquot wasdiluted in 225 ml G buffer and actin as depolymerized by incubation at 23 C for1 h. This aliquot was then centrifuged for 1 h at 80,000 g using a Beckman OptimaTL-100 and a TLA-100 rotor at 4 C to get rid of actin nuclei. 200 ml of thesupernatant containing 10 mM monomeric actin were taken carefully for actinassembly assays.
In polymerization experiments, monomeric pyrene-actin was used at a finalconcentration of 2 mM. After a 3 min incubation step with ME buffer (1 mMMgCl2, 1 mM EGTA) to exchange actin bound Ca2+ against Mg2+, proteins ofinterest in buffer B were added and reactions were started with 106KMEI. 100 mlof these mixtures were quickly applied to an UV cuvette and pyrene fluorescence(excited at 365 nm, emitted at 407 nm) was recorded.
For actin filament elongation assays, G-Mg buffer (G buffer with MgCl2 insteadof CaCl2), F-actin, buffer B with or without protein, and 106KMEI were mixed.The solution was sheared by passaging five times through a 27-gauge needle inorder to generate actin seeds. An invariable volume of this solution was mixedwith pre-incubated pyrenyl-actin and ME. 100 ml of this mixture were transferredinto a fluorescence cuvette. Pyrene fluorescence was monitored immediately. Finalconcentrations of actin and actin seeds used in these assays were 0.5 mM and333 nM, respectively.
In F-actin dilution assays, 10 mM actin (comprised with 5% pyrenyl-actin) waspolymerized by addition of 16 KMEI for 1 h at room temperature. F-actin was1:10 diluted into G buffer with 16KMEI in absence and presence of FHOD1 fland FHOD1 DC. The decay in fluorescence was monitored for 10 min.
For TIRFM, coverslips were gently cleaned with ethanol, Milli-Q water,Hellmanex II (Fluka, NO. 61257), and rinsed in Milli-Q water. Clean coverslipswere subsequently incubated with PEG-silane (MPEG-SIL-5000, 0.1 mg/ml in96% Ethanol) for 12 hours at room temperature. PEGylated coverslips were thenrinsed in Milli-Q water, air dried and stored at 4 C until use. Polymerizationexperiments were carried out in a Leica microscope (DMI 6000B) using 10 to 15%labeled G-actin (A488 rabbit muscle actin, Invitrogen). Images were takenevery 5 seconds using an EMCCD camera (Hamamatsu C9100-02), with theexcitation laser being shuttered between images to avoid photo-bleaching.Polymerization was started by the addition of 26 TIRF polymerization buffer(20 mM imidazole, 100 mM KCl, 2 mM MgCl2, 2 mM EGTA, 0.4 mM ATP,100 mM DTT, 2% methylcellulose, 10 mg/ml glucose oxidase, 50 mg/mlcatalase, 250 mg/ml glucose, pH 7.2–7.4). After the addition of the TIRFpolymerization buffer the sample was incubated 2 minutes on ice before it wasloaded onto the coverslip.
F-actin binding and bundling assay
Actin was isolated from acetone-dried powder prepared from rabbit skeletalmuscle as described (Mannherz et al., 2007). Actin was first depolymerized at5 mM on ice for 1 h in G buffer (5 mM Tris/HCl, pH 8.0 and 0.2 mM CaCl2,0.2 mM ATP, 0.5 mM DTT). After a centrifugation step (14,000 rpm, 30 min)actin was polymerized by addition of 106KMEI (500 mM KCl, 20 mM MgCl2,10 mM EGTA, 100 mM imidazole) for 2 h at 23 C. 5 mM phalloidin (Sigma) wasadded to the assay in order to stabilize F-actin. F-actin was added to the solutionscontaining proteins of interest using cut 200 ml tips and incubated 30 min at 23 C.After that, reaction mixtures were centrifuged at 80,000 g at 4 C for 20 min in aBeckman Optima TL-100 bench top ultracentrifuge using a TLA-100 rotor. 80 mlof the supernatants were taken and dried in a SpeedVac. The remainingsupernatant was removed and pellets were washed briefly with 100 mlpolymerization buffer. To both supernatants and pellets, 20 ml of 16 SDSsample buffer was added. 10 ml of the samples were applied to and analyzed byCoomassie-stained SDS-PAGE.
F-actin bundling assays were performed as described in the actin bindingsection. The only difference affected the centrifugation step after mixing of actinand probed proteins. Here, samples were applied to 10,000 g for 20 min at 4 Cusing a bench top centrifuge. In addition, F-actin bundling was probed by chemicalcross-linking using p-NN9-phenylene-bis-maleimide (PBM) as described (Knightand Offer, 1978) and confirmed by SDS-PAGE analysis performed as given(Hesterkamp et al., 1993). The PBM-generated ‘lower dimer’ obtained by cross-linking F-actin bundles obtained in the presence of 50 mM MgCl2 was purified bygel filtration as described (Silvan et al., 2012).
Electron microscopy
For EM analysis actin was polymerized by addition of 2 mM MgCl2 and diluted to0.1 mg/ml (2.4 mM) in polymerization buffer. Depending on the experimentalconditions gelsolin and tropomyosin were added at molar ratios of 1:100 and 1:7,respectively and incubated for 15 min at RT. Additionally, either FHOD1 DC orfull length FHOD1 at a concentration of 240 nM or 24 nM were added.
After 5 h or overnight incubation on ice, samples were prepared for electronmicroscopy similarly as described (Ohi et al., 2004). Briefly, a 3 ml drop of samplesolution was adsorbed for 45 sec to a freshly glow-discharged copper grid (AGARScientific) covered by a thin, continuous carbon film. Excess sample was blottedusing filter paper (Whatman No.4), washed twice with sample buffer and stainedfor 30 sec with 0.75% uranyl formate. Specimens were imaged at room
FHOD1 bundling in actin arcs 1899
Journ
alof
Cell
Scie
nce
temperature using a JEM1400 electron microscope (JEOL) equipped with a LaB6
electron source. The microscope was operated at an acceleration voltage of120 kV. Images were taken at a calibrated magnification of either 6,6606 or53,8006 and recorded on a 4k64k TemCam-F416 CMOS camera (TVIPS).
Life cell imaging and speckle microscopy
COS7 cells (ATCC, Teddington, UK) and Neuro-2a cells (DMSZ, Heidelberg)were cultured using standard conditions. For microscopy, 50,000 cells were platedon individual glass bottom dishes (MatTek Corp., Ashland) and transfected usingFugene-6 (Roche, Mannheim) on the following day according to themanufacturer’s protocol. The following day, cells were imaged via TIRFmicroscopy in CO2-independent growth medium containing serum and HEPES(Pan Biotech, Aidenbach) at 35 C in a home-built incubation chamber. For TIRFmicroscopy, an Olympus IX-81 microscope, equipped with a Plan APO 606 oilimmersion TIRF microscopy objective (NA51.45) and 1.6 optovar, was used. Atriple bandpass dichroic mirror (U-M3TIR405/488/561, Olympus, Hamburg) wascombined with Semrock Brightline emission filters (HC 520/35 and HC 629/53,AHF Analysentechnik, Tubingen) and CellR diode lasers 488 (20 mW), 561(25 mW). For detection, an EMCCD camera (C9100-13, Hamamatsu, Herrschingam Ammersee) was used at maximal gain. All microscope components werecontrolled by the CellR software (Olympus, Hamburg). For speckle microscopy,cells that express very low amounts of the FHOD1 constructs were selected. Inthese conditions, exposure times of at least 800 ms were required to visualizeindividual speckles. Image processing was performed using ImageJ (NIH,Bethesda) and Photoshop (Adobe, Munchen). Image manipulations were limitedto cropping, scaling, rotation, adjustment of levels, and addition of clearlyidentifiable labels or symbols. To correct for lateral drift in the stage position, animage stabilizer plugin for ImageJ was used (K. Li, ‘The image stabilizer pluginfor ImageJ’, http://www.cs.cmu.edu/,kangli/code/Image_Stabilizer.html,February 2008). The intensity levels in all image panels in time series areadjusted identically.
AcknowledgementsWe thank Karin Vogel-Bachmayr and Diana Ludwig for experttechnical assistance and Sascha Gentz for synthesis of the DADpeptide. In addition, we thank Naoki Watanabe (Tohoku University)for supplying the DCMV expression plasmid.
Author contributionsA.S. and M.G. designed the study. A.S. produced proteins and, withthe help of S.K., performed and analyzed in vitro actin assemblyexperiments. H.G.M. and A.J.M. performed cell transfectionexperiments. H.G.M., U.S. and C.A.S. did in vitro actinpolymerization TIRF microscopy. E.B., H.G.M. and S.R.performed electron microscopy measurements. L.D. performed andanalyzed live cell imaging. O.T.F. contributed with reagents anddiscussions. A.S. and M.G. wrote the manuscript with the help of allother authors. All authors discussed the results and commented onthe manuscript.
FundingThis work was supported in part by the DeutscheForschungsgemeinschaft [grant numbers GE-976/4 to M.G., FA-378/6 to O.T.F., MA-807/19 to H.G.M., and RA-1781/1 to S.R.]; andby the Fonds der Chemischen Industrie (stipend to E.B.).
Supplementary material available online at
http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.126706/-/DC1
ReferencesAlberts, A. S. (2001). Identification of a carboxyl-terminal diaphanous-related formin
homology protein autoregulatory domain. J. Biol. Chem. 276, 2824-2830.
Block, J., Breitsprecher, D., Kuhn, S., Winterhoff, M., Kage, F., Geffers, R., Duwe,
P., Rohn, J. L., Baum, B., Brakebusch, C. et al. (2012). FMNL2 drives actin-basedprotrusion and migration downstream of Cdc42. Curr. Biol. 22, 1005-1012.
Breitsprecher, D., Jaiswal, R., Bombardier, J. P., Gould, C. J., Gelles, J. and Goode,
B. L. (2012). Rocket launcher mechanism of collaborative actin assembly defined bysingle-molecule imaging. Science 336, 1164-1168.
Burnette, D. T., Manley, S., Sengupta, P., Sougrat, R., Davidson, M. W., Kachar,
B. and Lippincott-Schwartz, J. (2011). A role for actin arcs in the leading-edgeadvance of migrating cells. Nat. Cell Biol. 13, 371-382.
Chesarone, M. A., DuPage, A. G. and Goode, B. L. (2010). Unleashing formins toremodel the actin and microtubule cytoskeletons. Nat. Rev. Mol. Cell Biol. 11, 62-74.
Cramer, L. P., Siebert, M. and Mitchison, T. J. (1997). Identification of novel graded
polarity actin filament bundles in locomoting heart fibroblasts: implications for thegeneration of motile force. J. Cell Biol. 136, 1287-1305.
Dames, S. A., Junemann, A., Sass, H. J., Schonichen, A., Stopschinski, B. E.,
Grzesiek, S., Faix, J. and Geyer, M. (2011). Structure, dynamics, lipid binding, andphysiological relevance of the putative GTPase-binding domain of Dictyostelium
formin C. J. Biol. Chem. 286, 36907-36920.
Danuser, G. and Waterman-Storer, C. M. (2006). Quantitative fluorescent speckle
microscopy of cytoskeleton dynamics. Annu. Rev. Biophys. Biomol. Struct. 35, 361-387.
Gasteier, J. E., Madrid, R., Krautkramer, E., Schroder, S., Muranyi, W., Benichou,
S. and Fackler, O. T. (2003). Activation of the Rac-binding partner FHOD1 induces
actin stress fibers via a ROCK-dependent mechanism. J. Biol. Chem. 278, 38902-38912.
Gupton, S. L., Eisenmann, K., Alberts, A. S. and Waterman-Storer, C. M. (2007).mDia2 regulates actin and focal adhesion dynamics and organization in the lamellafor efficient epithelial cell migration. J. Cell Sci. 120, 3475-3487.
Hannemann, S., Madrid, R., Stastna, J., Kitzing, T., Gasteier, J., Schonichen, A.,
Bouchet, J., Jimenez, A., Geyer, M., Grosse, R. et al. (2008). The Diaphanous-
related Formin FHOD1 associates with ROCK1 and promotes Src-dependent plasmamembrane blebbing. J. Biol. Chem. 283, 27891-27903.
Harris, E. S., Rouiller, I., Hanein, D. and Higgs, H. N. (2006). Mechanistic differencesin actin bundling activity of two mammalian formins, FRL1 and mDia2. J. Biol.
Chem. 281, 14383-14392.
Hesterkamp, T., Weeds, A. G. and Mannherz, H. G. (1993). The actin monomers in
the ternary gelsolin: 2 actin complex are in an antiparallel orientation. Eur. J.
Biochem. 218, 507-513.
Higashida, C., Miyoshi, T., Fujita, A., Oceguera-Yanez, F., Monypenny, J., Andou,
Y., Narumiya, S. and Watanabe, N. (2004). Actin polymerization-driven molecular
movement of mDia1 in living cells. Science 303, 2007-2010.
Hotulainen, P. and Lappalainen, P. (2006). Stress fibers are generated by two distinct
actin assembly mechanisms in motile cells. J. Cell Biol. 173, 383-394.
Iskratsch, T., Lange, S., Dwyer, J., Kho, A. L., dos Remedios, C. and Ehler,
E. (2010). Formin follows function: a muscle-specific isoform of FHOD3 is regulatedby CK2 phosphorylation and promotes myofibril maintenance. J. Cell Biol. 191,1159-1172.
Jurmeister, S., Baumann, M., Balwierz, A., Keklikoglou, I., Ward, A., Uhlmann, S.,
Zhang, J. D., Wiemann, S. and Sahin, O. (2012). MicroRNA-200c represses
migration and invasion of breast cancer cells by targeting actin-regulatory proteinsFHOD1 and PPM1F. Mol. Cell. Biol. 32, 633-651.
Knight, P. and Offer, G. (1978). p-NN9-phenylenebismaleimide, a specific cross-linking agent for F-actin. Biochem. J. 175, 1023-1032.
Kovar, D. R. and Pollard, T. D. (2004). Insertional assembly of actin filament barbedends in association with formins produces piconewton forces. Proc. Natl. Acad. Sci.
USA 101, 14725-14730.
Legate, K. R., Takahashi, S., Bonakdar, N., Fabry, B., Boettiger, D., Zent, R. and
Fassler, R. (2011). Integrin adhesion and force coupling are independently regulatedby localized PtdIns(4,5)2 synthesis. EMBO J. 30, 4539-4553.
Li, F. and Higgs, H. N. (2003). The mouse Formin mDia1 is a potent actin nucleationfactor regulated by autoinhibition. Curr. Biol. 13, 1335-1340.
Mannherz, H. G., Ballweber, E., Galla, M., Villard, S., Granier, C., Steegborn, C.,
Schmidtmann, A., Jaquet, K., Pope, B. and Weeds, A. G. (2007). Mapping theADF/cofilin binding site on monomeric actin by competitive cross-linking and
peptide array: evidence for a second binding site on monomeric actin. J. Mol. Biol.
366, 745-755.
Mi-Mi, L., Votra, S., Kemphues, K., Bretscher, A. and Pruyne, D. (2012). Z-lineformins promote contractile lattice growth and maintenance in striated muscles of C.
elegans. J. Cell Biol. 198, 87-102.
Miyoshi, T., Tsuji, T., Higashida, C., Hertzog, M., Fujita, A., Narumiya, S., Scita, G.
and Watanabe, N. (2006). Actin turnover-dependent fast dissociation of cappingprotein in the dendritic nucleation actin network: evidence of frequent filamentsevering. J. Cell Biol. 175, 947-955.
Moseley, J. B. and Goode, B. L. (2005). Differential activities and regulation ofSaccharomyces cerevisiae formin proteins Bni1 and Bnr1 by Bud6. J. Biol. Chem.
280, 28023-28033.
Moseley, J. B., Sagot, I., Manning, A. L., Xu, Y., Eck, M. J., Pellman, D. and Goode,
B. L. (2004). A conserved mechanism for Bni1- and mDia1-induced actin assemblyand dual regulation of Bni1 by Bud6 and profilin. Mol. Biol. Cell 15, 896-907.
Ohi, M., Li, Y., Cheng, Y. and Walz, T. (2004). Negative Staining and ImageClassification - Powerful Tools in Modern Electron Microscopy. Biol. Proced. Online
6, 23-34.
Okada, K., Bartolini, F., Deaconescu, A. M., Moseley, J. B., Dogic, Z., Grigorieff,
N., Gundersen, G. G. and Goode, B. L. (2010). Adenomatous polyposis coli proteinnucleates actin assembly and synergizes with the formin mDia1. J. Cell Biol. 189,
1087-1096.
Perera, H. D., Ma, Y. Q., Yang, J., Hirbawi, J., Plow, E. F. and Qin, J. (2011).
Membrane binding of the N-terminal ubiquitin-like domain of kindlin-2 is crucial forits regulation of integrin activation. Structure 19, 1664-1671.
Quinlan, M. E., Hilgert, S., Bedrossian, A., Mullins, R. D. and Kerkhoff, E. (2007).Regulatory interactions between two actin nucleators, Spire and Cappuccino. J. Cell
Biol. 179, 117-128.
Ridley, A. J. (2011). Life at the leading edge. Cell 145, 1012-1022.
Journal of Cell Science 126 (8)1900
Journ
alof
Cell
Scie
nce
Romero, S., Le Clainche, C., Didry, D., Egile, C., Pantaloni, D. and Carlier, M. F.(2004). Formin is a processive motor that requires profilin to accelerate actinassembly and associated ATP hydrolysis. Cell 119, 419-429.
Schonichen, A. and Geyer, M. (2010). Fifteen formins for an actin filament: amolecular view on the regulation of human formins. Biochim. Biophys. Acta 1803,152-163.
Schonichen, A., Alexander, M., Gasteier, J. E., Cuesta, F. E., Fackler, O. T. and
Geyer, M. (2006). Biochemical characterization of the diaphanous autoregulatoryinteraction in the formin homology protein FHOD1. J. Biol. Chem. 281, 5084-5093.
Schulte, A., Stolp, B., Schonichen, A., Pylypenko, O., Rak, A., Fackler, O. T. and
Geyer, M. (2008). The human formin FHOD1 contains a bipartite structure of FH3and GTPase-binding domains required for activation. Structure 16, 1313-1323.
Silvan, U., Boiteux, C., Sutterlin, R., Schroeder, U., Mannherz, H. G., Jockusch,B. M., Berneche, S., Aebi, U. and Schoenenberger, C. A. (2012). An antiparallelactin dimer is associated with the endocytic pathway in mammalian cells. J. Struct.
Biol. 177, 70-80.Sparrow, J. C. and Schock, F. (2009). The initial steps of myofibril assembly: integrins
pave the way. Nat. Rev. Mol. Cell Biol. 10, 293-298.Staus, D. P., Blaker, A. L., Medlin, M. D., Taylor, J. M. and Mack, C. P. (2011).
Formin homology domain-containing protein 1 regulates smooth muscle cellphenotype. Arterioscler. Thromb. Vasc. Biol. 31, 360-367.
Takeya, R. and Sumimoto, H. (2003). Fhos, a mammalian formin, directly binds to F-actin via a region N-terminal to the FH1 domain and forms a homotypic complex viathe FH2 domain to promote actin fiber formation. J. Cell Sci. 116, 4567-4575.
Takeya, R., Taniguchi, K., Narumiya, S. and Sumimoto, H. (2008). The mammalianformin FHOD1 is activated through phosphorylation by ROCK and mediatesthrombin-induced stress fibre formation in endothelial cells. EMBO J. 27, 618-628.
Taniguchi, K., Takeya, R., Suetsugu, S., Kan-O, M., Narusawa, M., Shiose, A.,
Tominaga, R. and Sumimoto, H. (2009). Mammalian formin fhod3 regulates actin
assembly and sarcomere organization in striated muscles. J. Biol. Chem. 284, 29873-
29881.
Tojkander, S., Gateva, G., Schevzov, G., Hotulainen, P., Naumanen, P., Martin, C.,
Gunning, P. W. and Lappalainen, P. (2011). A molecular pathway for myosin II
recruitment to stress fibers. Curr. Biol. 21, 539-550.
Tominaga, T., Sahai, E., Chardin, P., McCormick, F., Courtneidge, S. A. and
Alberts, A. S. (2000). Diaphanous-related formins bridge Rho GTPase and Src
tyrosine kinase signaling. Mol. Cell 5, 13-25.
Tu, D., Graziano, B. R., Park, E., Zheng, W., Li, Y., Goode, B. L. and Eck, M. J.
(2012). Structure of the formin-interaction domain of the actin nucleation-promoting
factor Bud6. Proc. Natl. Acad. Sci. USA 109, E3424-E3433.
Watanabe, N. and Mitchison, T. J. (2002). Single-molecule speckle analysis of actin
filament turnover in lamellipodia. Science 295, 1083-1086.
Watanabe, N., Kato, T., Fujita, A., Ishizaki, T. and Narumiya, S. (1999).
Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat.
Cell Biol. 1, 136-143.
Westendorf, J. J. (2001). The formin/diaphanous-related protein, FHOS, interacts with
Rac1 and activates transcription from the serum response element. J. Biol. Chem. 276,
46453-46459.
Wojciak-Stothard, B., Potempa, S., Eichholtz, T. and Ridley, A. J. (2001). Rho and
Rac but not Cdc42 regulate endothelial cell permeability. J. Cell Sci. 114, 1343-1355.
Zigmond, S. H., Evangelista, M., Boone, C., Yang, C., Dar, A. C., Sicheri, F.,
Forkey, J. and Pring, M. (2003). Formin leaky cap allows elongation in the presence
of tight capping proteins. Curr. Biol. 13, 1820-1823.
FHOD1 bundling in actin arcs 1901
Recommended